ENHANCING IMMUNOTHERAPY FOR TRIPLE-NEGATIVE AND HER2+ BREAST CANCER USING EPCAM APTAMER-SIRNA-MEDIATED GENE KNOCKDOWN.

$530,899FY2019Department of the ArmyDOD

Children'S Hospital Corporation, The

Investigators